Wearable injectors (Wis) are medical devices that are used to administer bigger amounts (more than 2 mL) of medication subcutaneously over a long period of time. On-body, off-body, and hand-held injectors are the three types of wearable injectors. On-body injectors, also known as on-body delivery systems, provide a pre-measured amount of drug, frequently automatically via a needle, ensuring that the patient does not skip a treatment or misapply their own medication. Massive volume wearable injectors, on the other hand, have the ability to store large amounts of medications.
Because wearable injectors are projected to be utilised in more clinics and hospitals than they are now, more pharmaceutical companies are expected to strive to break into the market and drive up demand. In February 2020, for example, Becton, Dickinson and Company, a medical device company based in the United States, announced the completion of a 50-subject human clinical trial with the BD Libertas Wearable Injector, which is designed to deliver biologics with viscosities up to 50 cP in 2-5 mL and 5-10 mL configurations. Furthermore, Phillips-Medisize and Subcuject cooperated in February 2021 to bring a wearable bolus injector to market.
Read More: https://bit.ly/3vyyXjy
